One Health Group Plc · LSE:OHGR
One Health — FY2025 Earnings Presentation
24 slides from One Health's earnings presentation, Jun 23, 2025
Slide 1: One Health Group: 2025 Full Year Results
One Health Group: 2025 Full Year Results 23rd June – 15:30
Slide 2: Senior management team
Senior management team • Derek founded One Health in 2004 and is • Prior to joining One Health in 2018, Adam recognised as one of the UK’s leading worked extensively in senior financial, knee surgeons. commercial and operational roles across retail, logistics and manufacturing. • Derek provided surg
Slide 3: Introduction to One Health
Introduction to One Health Profitable, growing, cash generative, dividend paying Trading for more than 20 years, One Health engages over One Health is a fundamental part of the local NHS supply 130 NHS Consultants and anaesthetists to support the NHS chain providing services to underserved areas tho
Slide 4: One Health in numbers
One Health in numbers In FY 251, One Health received 17,020 new patient referrals, FY 25 turnover of c. £28.4m (FY 242: £23.0m), an organic carried out 42,238 consultations & 7,043 surgical increase of more than 23% procedures through 9 independent hospitals FY 25 underlying EBITDA of £2.0m (FY 242:
Slide 5: 'Patient Choice'
‘Patient Choice’ NHS patients have a statutory right to choose their provider Indicative allocation of revenue received from NHS* of treatment including independent sector providers One Health New NHS and independent sector agreement aimed to help Gross Margin tackle waiting lists and actively promo
Slide 6: The One Health model
The One Health model NHS Patient Chooses One Health via Patient Choice or through direct referral NHS patient backlog unmanageable without support Providing capacity in under resourced areas Surgeons with • Surgery and patient scheduling additional capacity • Hospital patient liaison Contracted as c
Slide 7: Why patients choose One Health
Why patients choose One Health Shorter average waiting times from GP Consultations and physiotherapy services Patients are allocated the same NHS referral to first appointment. Target wait delivered from 3rd party community based consultant at every stage time of 6-10 weeks from consultation to and
Slide 8: Operational overview and growth drivers (1/3) Patient Demand
Operational overview and growth drivers (1/3) Patient Demand More patients 28% increase in new NHS patient referrals to 17,020 referrals in FY 25 (FY 24 13,266 referrals) The Government are actively promoting ‘Patient Choice’ and the increased use of the independent sector to tackle very high Increa
Slide 9: Operational overview and growth drivers (2/3) Surgeon Availability
Operational overview and growth drivers (2/3) Surgeon Availability 15 new sub-contracted clinicians have joined the Group since More consultants April 2024 supporting growth c.30 more consultant surgeons in the ‘pipeline’ Increasing number of surgeons as One Health widens its geographic operating ar
Slide 10: Operational overview and growth drivers (3/3) Operating Capacity
Operational overview and growth drivers (3/3) Operating Capacity More capacity Operating theatre capacity being rapidly increased with a 14% increase in surgical procedures in FY 25 compared to FY 24 Continue to add new independent hospitals to our supply network (FY 25 13% increase) Plans well adva
Slide 11: Current and future geographic coverage
Current and future geographic Current footprint Within 3 Years coverage Within 5 Years Proposed first hub Targeted hub locations Continued organic growth focused on areas with : • Lack of NHS and independent infrastructure and capacity • Relatively high population density • Low private medical insur
Slide 12: Surgical hubs
Surgical hubs The development of surgical hubs is key to One Health’s longer-term accelerated strategic growth Supporting NHS demand and providing capacity in under resourced areas The Prime Ministers Office stated on the 6th of January 2025, that the There is significant scope for strategic growth
Slide 13: Financial benefit of surgical hubs – driving margin accretion
Financial benefit of surgical hubs – driving margin accretion c.18% Gross c.18% Gross Margin Margin c.12% Incremental Increased margin Gross Margin* High Density regions (Third-party operating theatres) *Subject to final costs and operating hours. 13
Slide 14: Surgical hub illustrative overview
Surgical hub illustrative overview Overview: • Total site area 7.2k m2 building footprint 1.4k m2 • One laminar flow theatre complex • 12 single en-suite patient rooms. • Total expected cost for first hub (including land) of c. £8m to £9m • Reception area • Staff changing rooms & restroom • Highly e
Slide 15: Surgical hub illustrative overview
Surgical hub illustrative overview 15
Slide 16: Surgical hub progress
Surgical hub progress • First hub to be funded from existing cash reserves including placing proceeds received this year • Offer accepted of £700k and exchanged on land (STP) in an area that is underserved by both the NHS and private hospitals with significant NHS waiting lists • Full planning submi
Slide 17: Financials
Financials
Slide 18: FY 25 - Highlights
FY 25 - Highlights • Revenue of c. £28.4 million, an increase of 23% on FY 242 (£23.0m) • Underlying EBITDA of £2.0m, a significant increase on FY 242 (£1.5m) • Cash at 31 March 2025 of £11.4 m1 (FY 24: £4.7m), supporting first hub development and progressive dividend policy • 28% increase in new pa
Slide 19: FY 25 – Significant Growth: Operational KPI's
FY 25 – Significant Growth: Operational KPI’s 2025 2024 (%) 2024 2023 (%) New Patient Referrals 17,020 13,266 +28% 13,266 11,747 +13% Number of consultations 42,238 33,695 +25% 33,695 29,025 +16% Number of surgical procedures 7,043 6,169 +14% 6,169 5,790 +7% Number of consultants (excluding anaesthe
Slide 20: FY 25 – Significant Growth: Financial KPI's
FY 25 – Significant Growth: Financial KPI’s 2024 restated under IFRS with consolidation of EBT and a legacy property valuation adjustment. 2025 2024 (%) 2023 2022 Revenue (£m) 28.4 23.0 +23% 20.2 17.0 Gross profit (£m) 5.4 4.0 +34% 3.6 3.6 Underlying EBITDA(£m) 2.02 1.52 +33% 1.63 1.4 Underlying EPS
Slide 21: FY 25 – Significant Growth: Underlying EBITDA
FY 25 – Significant Growth: Underlying EBITDA 2024 Restated under IFRS with consolidation of EBT and a legacy property valuation adjustment. Underlying EBITDA 2025 2024 Reported Profit for the year 1,077,905 707,941 Adjust for: Depreciation 134,359 134,250 Interest (Net) (58,082) 76,619 Taxation cha
Slide 22: Outlook
Outlook “I’m not going to allow working people to Strong organic growth: wait longer than is necessary, when we can get them treated sooner in a private • The current Government is expected to have a positive effect with continued hospital, paid for by the NHS” increase in the use of the independent
Slide 23: One Health Group addresses a growing market need
One Health Group addressees a growing market need • Part of the NHS supply chain, supporting the growing waiting lists using NHS personnel & resources • Aligned with current Government policy as recently outlined by the forthcoming ‘Elective Reform Plan’ and the new NHSE independent sector partnersh
Slide 24: ()
()